Wellington Management Group LLP decreased its position in Chemed Co. (NYSE:CHE – Free Report) by 95.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,242 shares of the company’s stock after selling 65,275 shares during the quarter. Wellington Management Group LLP’s holdings in Chemed were worth $1,948,000 at the end of the most recent quarter.
A number of other institutional investors have also made changes to their positions in the company. HighTower Advisors LLC increased its stake in Chemed by 78.0% during the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company’s stock worth $2,246,000 after buying an additional 1,634 shares during the period. Hsbc Holdings PLC grew its stake in shares of Chemed by 110.0% during the second quarter. Hsbc Holdings PLC now owns 10,638 shares of the company’s stock valued at $5,801,000 after acquiring an additional 5,572 shares in the last quarter. Evergreen Capital Management LLC purchased a new stake in shares of Chemed during the second quarter worth about $7,812,000. Quest Partners LLC lifted its stake in shares of Chemed by 634.3% in the second quarter. Quest Partners LLC now owns 1,990 shares of the company’s stock worth $1,080,000 after acquiring an additional 1,719 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in Chemed by 1.5% in the second quarter. Envestnet Asset Management Inc. now owns 74,461 shares of the company’s stock valued at $40,401,000 after purchasing an additional 1,106 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.
Chemed Trading Down 1.2 %
Shares of CHE opened at $518.59 on Thursday. Chemed Co. has a 52 week low of $516.91 and a 52 week high of $654.62. The firm has a market cap of $7.80 billion, a price-to-earnings ratio of 26.20, a PEG ratio of 2.32 and a beta of 0.46. The stock has a 50 day moving average of $568.69 and a 200-day moving average of $564.69.
Chemed Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Monday, November 18th were issued a $0.50 dividend. The ex-dividend date of this dividend was Monday, November 18th. This represents a $2.00 dividend on an annualized basis and a yield of 0.39%. Chemed’s dividend payout ratio is currently 10.11%.
Wall Street Analyst Weigh In
CHE has been the topic of a number of recent analyst reports. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada reduced their price objective on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.
Get Our Latest Stock Analysis on CHE
Insider Buying and Selling at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $572.77, for a total value of $1,145,540.00. Following the sale, the chief executive officer now owns 101,735 shares of the company’s stock, valued at $58,270,755.95. This trade represents a 1.93 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction dated Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the transaction, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 11.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 5,132 shares of company stock worth $3,003,502 over the last ninety days. Company insiders own 3.32% of the company’s stock.
Chemed Company Profile
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
See Also
- Five stocks we like better than Chemed
- What is a Special Dividend?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- High Flyers: 3 Natural Gas Stocks for March 2022
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.